ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.07 -0.05 (-1.21%)
At close: Oct 2, 2026 · 4:00 PM EDT

ARS Pharmaceuticals (SPRY) Change in Accured Expenses (2020 - 2026)

Updated

ARS Pharmaceuticals' Change in Accured Expenses came in at $10.52 million for Q2 2026, down 17.9% from $12.81 million a year earlier but up 2.0% from the prior quarter.

Analysis

ARS Pharmaceuticals (SPRY) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, ARS Pharmaceuticals reported Change in Accured Expenses of $22.74 million, down 21.5% year-over-year; for FY2025, it was $18.88 million, up 15.0% from FY2024.

  • Change in Accured Expenses carries a five-year compound annual growth rate of 60.2% (FY2020 to FY2025).
  • Going back by year, Change in Accured Expenses was $16.41 million in FY2024, -$2.78 million in FY2023, -$10.29 million in FY2022 and $974,000 in FY2021 (-45.6%).
  • The five-year range for quarterly Change in Accured Expenses is -$11.42 million (Q4 2022) to $12.81 million (Q2 2025).
  • Year-over-year, Change in Accured Expenses increased in five of the last six quarters, with growth averaging 182.7%.
  • The fastest year-over-year change in Change in Accured Expenses over five years came in Q1 2023 (growth of 771.1%), and the weakest in Q1 2022 (a decline of 75.3%).
  • Business Quant data shows SPRY's Change in Accured Expenses at $10.32 million (Q1 2026), -$9.06 million (Q4 2025) and $10.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 ARS Pharmaceuticals 404.71 Mn 260.91 Mn 20.81 Mn 10.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.52 Mn
Mar 31, 2026 10.32 Mn
Dec 31, 2025 -9.06 Mn
Sep 30, 2025 10.96 Mn
Jun 30, 2025 12.81 Mn
Mar 31, 2025 4.17 Mn
Dec 31, 2024 7.66 Mn
Sep 30, 2024 4.34 Mn
Jun 30, 2024 3.07 Mn
Mar 31, 2024 1.34 Mn
Dec 31, 2023 -8.88 Mn
Sep 30, 2023 1.12 Mn
Jun 30, 2023 224,000.00
Mar 31, 2023 4.76 Mn
Dec 31, 2022 -11.42 Mn
Sep 30, 2022 859,000.00
Jun 30, 2022 -267,000.00
Mar 31, 2022 546,000.00
Dec 31, 2021 -5.45 Mn
Sep 30, 2021 -367,000.00
API Access

ARS Pharmaceuticals Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=SPRY&period=max&api_key=YOUR_API_KEY